Salix Pharmaceuticals RX
FDA Approved Drugs

Salix Pharmaceuticals RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 12
  • Latest Approval Date Jan 19, 2017
  • Data Source FDA
  • First Approval Date Jun 06, 1984
All
30
View
Discontinued
18
View
RX
12
View
Company Overview

Company

Salix Pharmaceuticals RX

Country

U.S.A

Website

Visit Website

Email

Salixmc@dlss.com

Social Profiles

LinkedIn
Company Snapshot

Salix Pharmaceuticals RX

400 Somerset Corporate Blvd. Bridgewater, NJ 08807 USA

U.S.A

www.salix.com/ Salixmc@dlss.com View on Map
FDA Approved Drug Records ( 12 records )
1984
06 Jun
RX Application: 88250

Drug Name

ANUSOL HC

Product Number

1

Dosage Form

-

Strength

2.5%

Approval Date

1984-06-06

88250 / 1

Active Ingredient

HYDROCORTISONE

Application Number

88250

Product Number

1

Dosage Form

-

Strength

2.5%

Approval Date

1984-06-06

Regulatory Status

RX

2008
31 Oct
RX Application: 22301

Drug Name

APRISO

Product Number

1

Dosage Form

-

Strength

375MG

Approval Date

2008-10-31

22301 / 1

Active Ingredient

MESALAMINE

Application Number

22301

Product Number

1

Dosage Form

-

Strength

375MG

Approval Date

2008-10-31

Regulatory Status

RX

2006
02 Aug
RX Application: 21881

Drug Name

MOVIPREP

Product Number

1

Dosage Form

-

Strength

4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM

Approval Date

2006-08-02

21881 / 1

Active Ingredient

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Application Number

21881

Product Number

1

Dosage Form

-

Strength

4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM

Approval Date

2006-08-02

Regulatory Status

RX

2008
24 Apr
RX Application: 21964

Drug Name

RELISTOR

Product Number

1

Dosage Form

-

Strength

12MG/0.6ML (12MG/0.6ML)

Approval Date

2008-04-24

21964 / 1

Active Ingredient

METHYLNALTREXONE BROMIDE

Application Number

21964

Product Number

1

Dosage Form

-

Strength

12MG/0.6ML (12MG/0.6ML)

Approval Date

2008-04-24

Regulatory Status

RX

2010
27 Sep
RX Application: 21964

Drug Name

RELISTOR

Product Number

2

Dosage Form

-

Strength

8MG/0.4ML (8MG/0.4ML)

Approval Date

2010-09-27

21964 / 2

Active Ingredient

METHYLNALTREXONE BROMIDE

Application Number

21964

Product Number

2

Dosage Form

-

Strength

8MG/0.4ML (8MG/0.4ML)

Approval Date

2010-09-27

Regulatory Status

RX

2010
27 Sep
RX Application: 21964

Drug Name

RELISTOR

Product Number

3

Dosage Form

-

Strength

12MG/0.6ML (12MG/0.6ML)

Approval Date

2010-09-27

21964 / 3

Active Ingredient

METHYLNALTREXONE BROMIDE

Application Number

21964

Product Number

3

Dosage Form

-

Strength

12MG/0.6ML (12MG/0.6ML)

Approval Date

2010-09-27

Regulatory Status

RX

2016
19 Jul
RX Application: 208271

Drug Name

RELISTOR

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2016-07-19

208271 / 1

Active Ingredient

METHYLNALTREXONE BROMIDE

Application Number

208271

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2016-07-19

Regulatory Status

RX

2017
19 Jan
RX Application: 208745

Drug Name

TRULANCE

Product Number

1

Dosage Form

-

Strength

3MG

Approval Date

2017-01-19

208745 / 1

Active Ingredient

PLECANATIDE

Application Number

208745

Product Number

1

Dosage Form

-

Strength

3MG

Approval Date

2017-01-19

Regulatory Status

RX

2013
14 Jan
RX Application: 203634

Drug Name

UCERIS

Product Number

1

Dosage Form

-

Strength

9MG

Approval Date

2013-01-14

203634 / 1

Active Ingredient

BUDESONIDE

Application Number

203634

Product Number

1

Dosage Form

-

Strength

9MG

Approval Date

2013-01-14

Regulatory Status

RX

2014
07 Oct
RX Application: 205613

Drug Name

UCERIS

Product Number

1

Dosage Form

-

Strength

2MG/ACTUATION

Approval Date

2014-10-07

205613 / 1

Active Ingredient

BUDESONIDE

Application Number

205613

Product Number

1

Dosage Form

-

Strength

2MG/ACTUATION

Approval Date

2014-10-07

Regulatory Status

RX

2004
25 May
RX Application: 21361

Drug Name

XIFAXAN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2004-05-25

21361 / 1

Active Ingredient

RIFAXIMIN

Application Number

21361

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2004-05-25

Regulatory Status

RX

2010
24 Mar
RX Application: 21361

Drug Name

XIFAXAN

Product Number

2

Dosage Form

-

Strength

550MG

Approval Date

2010-03-24

21361 / 2

Active Ingredient

RIFAXIMIN

Application Number

21361

Product Number

2

Dosage Form

-

Strength

550MG

Approval Date

2010-03-24

Regulatory Status

RX

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    30 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ANUSOL HC

Application Number

88250

Product Number

1

Active Ingredient

HYDROCORTISONE

Dosage Form

-

Strength

2.5%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit